Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus Germline BRCA mutations: a Meta-analysis and systematic review.

Saved in:
Bibliographic Details
Title: Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus Germline BRCA mutations: a Meta-analysis and systematic review.
Authors: Mohyuddin GR; University of Kansas, Kansas City, USA., Aziz M; Department of Internal Medicine, University of Toledo, Toledo, USA., Britt A; Department of Internal Medicine, University of Kansas, Kansas City, USA., Wade L; University of Toledo Libraries, Toledo, USA., Sun W; Division of Medical Oncology, University of Kansas Cancer Center, Kansas City, USA., Baranda J; Division of Medical Oncology, University of Kansas Cancer Center, Kansas City, USA., Al-Rajabi R; Division of Medical Oncology, University of Kansas Cancer Center, Kansas City, USA., Saeed A; Division of Medical Oncology, University of Kansas Cancer Center, Kansas City, USA., Kasi A; Division of Medical Oncology, University of Kansas Cancer Center, Kansas City, USA. akasi@kumc.edu.
Source: BMC cancer [BMC Cancer] 2020 Jun 03; Vol. 20 (1), pp. 507. Date of Electronic Publication: 2020 Jun 03.
Publication Type: Comparative Study; Journal Article; Meta-Analysis; Systematic Review
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1471-2407
DOI:10.1186/s12885-020-06948-5